View in EDS

Phase 1 Study of IMC-002, a Next-Generation Anti-CD47 Antibody, in Advanced Solid Tumors.

Saved in:
Bibliographic Details
Title: Phase 1 Study of IMC-002, a Next-Generation Anti-CD47 Antibody, in Advanced Solid Tumors.
Authors: Ahn JS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Hong JY; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Park JO; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Lee SY; ImmuneOncia Therapeutics Inc., Seoul, Korea., Kim S; ImmuneOncia Therapeutics Inc., Seoul, Korea., Yun HY; College of Pharmacy, Chungnam National University, Daejeon, Korea., Ock CY; Lunit Inc., Seoul, Korea., Hwang W; Lunit Inc., Seoul, Korea., Kim SH; ImmuneOncia Therapeutics Inc., Seoul, Korea., Kim HT; ImmuneOncia Therapeutics Inc., Seoul, Korea., Lim HY; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Source: Cancer research and treatment [Cancer Res Treat] 2025 Nov 04. Date of Electronic Publication: 2025 Nov 04.
Publication Type: Journal Article
Journal Info: Publisher: Korean Cancer Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-9256 (Electronic) Linking ISSN: 15982998 NLM ISO Abbreviation: Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41197525
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase 1 Study of IMC-002, a Next-Generation Anti-CD47 Antibody, in Advanced Solid Tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ahn+JS%22">Ahn JS</searchLink>; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Hong+JY%22">Hong JY</searchLink>; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Park+JO%22">Park JO</searchLink>; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Lee+SY%22">Lee SY</searchLink>; ImmuneOncia Therapeutics Inc., Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Kim+S%22">Kim S</searchLink>; ImmuneOncia Therapeutics Inc., Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Yun+HY%22">Yun HY</searchLink>; College of Pharmacy, Chungnam National University, Daejeon, Korea.<br /><searchLink fieldCode="AU" term="%22Ock+CY%22">Ock CY</searchLink>; Lunit Inc., Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Hwang+W%22">Hwang W</searchLink>; Lunit Inc., Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Kim+SH%22">Kim SH</searchLink>; ImmuneOncia Therapeutics Inc., Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Kim+HT%22">Kim HT</searchLink>; ImmuneOncia Therapeutics Inc., Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Lim+HY%22">Lim HY</searchLink>; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101155137%22">Cancer research and treatment</searchLink> [Cancer Res Treat] 2025 Nov 04. <i>Date of Electronic Publication: </i>2025 Nov 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Korean+Cancer+Association%22">Korean Cancer Association </searchLink><i>Country of Publication: </i>Korea (South) <i>NLM ID: </i>101155137 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2005-9256 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215982998%22">15982998 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Res Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41197525
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.4143/crt.2025.820
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Phase 1 Study of IMC-002, a Next-Generation Anti-CD47 Antibody, in Advanced Solid Tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ahn JS
      – PersonEntity:
          Name:
            NameFull: Hong JY
      – PersonEntity:
          Name:
            NameFull: Park JO
      – PersonEntity:
          Name:
            NameFull: Lee SY
      – PersonEntity:
          Name:
            NameFull: Kim S
      – PersonEntity:
          Name:
            NameFull: Yun HY
      – PersonEntity:
          Name:
            NameFull: Ock CY
      – PersonEntity:
          Name:
            NameFull: Hwang W
      – PersonEntity:
          Name:
            NameFull: Kim SH
      – PersonEntity:
          Name:
            NameFull: Kim HT
      – PersonEntity:
          Name:
            NameFull: Lim HY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 11
              Text: 2025 Nov 04
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2005-9256
          Titles:
            – TitleFull: Cancer research and treatment
              Type: main
ResultId 1